The Cooper Companies Announces Its Subsidiary CooperVision Has Received FDA Special 510(K) Clearance on Its Avaira Toric Contact Lenses
The Cooper Companies, Inc. (NYSE: COO) today announced that the U.S. Food and Drug Administration has granted a Special 510(k) clearance for CooperVision's Avaira® Toric two-week silicone hydrogel contact lenses for astigmatism.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.